neurological disorders

IPO initial public offering Wall Street
Biotech

Big Pharma-backed MapLight plots IPO

Should the listing go through, MapLight would become just the second biotech to go public since February.
Darren Incorvaia Sep 22, 2025 1:57pm
Crossing crosswalk walking road

Ionis rare disease candidate ekes out phase 3 win

Sep 22, 2025 10:46am
Racecar speeding down a track

Servier supercharges neuro pipeline with $450M deal

Sep 8, 2025 2:30am
white hawk bird flying

Merck KGaA swoops to $2B neurological disease pact with Skyhawk

Aug 18, 2025 9:49am
brain

Arialys presents promising data for IgG1 antibody treatment

Jun 20, 2025 5:02am
Cartoon of businessmen standing around a broken target

Vigil's rare brain disease drug flunks phase 2 study

Jun 4, 2025 9:45am